Camber Capital Management

Camber Capital Management as of March 31, 2018

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 32 positions in its portfolio as reported in the March 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Shire 8.1 $164M 1.1M 149.39
Nektar Therapeutics (NKTR) 7.8 $159M 1.5M 106.26
Allergan 7.0 $143M 850k 168.29
Biogen Idec (BIIB) 6.9 $141M 515k 273.82
Hca Holdings (HCA) 6.0 $121M 1.3M 97.00
Envision Healthcare 5.4 $110M 2.9M 38.43
Tenet Healthcare Corporation (THC) 5.1 $103M 4.3M 24.25
Tesaro 4.8 $99M 1.7M 57.14
Universal Health Services (UHS) 4.5 $92M 780k 118.41
Bristol Myers Squibb (BMY) 3.9 $79M 1.3M 63.25
Genomic Health 3.8 $77M 2.5M 31.29
Medicines Company 3.2 $66M 2.0M 32.94
Atara Biotherapeutics (ATRA) 3.1 $63M 1.6M 39.00
NuVasive 3.1 $63M 1.2M 52.21
GlaxoSmithKline 2.9 $59M 1.5M 39.07
Global Blood Therapeutics In 2.9 $58M 1.2M 48.30
AMAG Pharmaceuticals 2.6 $53M 2.7M 20.15
Mylan Nv 2.5 $52M 1.3M 41.17
Myriad Genetics (MYGN) 2.2 $44M 1.5M 29.55
Brookdale Senior Living (BKD) 2.1 $44M 6.5M 6.71
Clovis Oncology 2.1 $44M 825k 52.80
Endologix 1.9 $39M 9.3M 4.23
Perrigo Company (PRGO) 1.6 $33M 400k 83.34
Cardiovascular Systems 1.3 $27M 1.2M 21.93
K2m Group Holdings 1.3 $26M 1.3M 18.95
Valeant Pharmaceuticals Int 1.2 $24M 1.5M 15.92
Wright Medical Group Nv 0.8 $16M 815k 19.84
Endo International (ENDPQ) 0.7 $15M 2.5M 5.94
Dicerna Pharmaceuticals 0.5 $9.6M 1.0M 9.56
Prothena (PRTA) 0.5 $9.2M 250k 36.71
Momenta Pharmaceuticals 0.1 $2.5M 135k 18.15
Surgery Partners (SGRY) 0.1 $2.3M 135k 17.15